Proteasome inhibitor and corticosteroid combination
This page covers all Proteasome inhibitor and corticosteroid combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Proteasome.
Targets
Phase 3 pipeline (1)
- Velcade-Dexamethasone · Intergroupe Francophone du Myelome · Oncology
Velcade-Dexamethasone is a combination of a proteasome inhibitor and a corticosteroid used to treat multiple myeloma.